Navigation Links
Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia

ther than 16, suggesting cross-reactivity.

In a second presentation of data from the same cohort of 58 evaluable patients, CD4 and CD8 positive T cells were activated with pooled E6 and E7 peptides and tested for interferon gamma production and degranulation. Blinded histologic sections of the final cervical conization specimens were independently graded for inflammation using a standardized protocol (0 no inflammation and 4 the highest level of inflammation.). There was significantly more cervical inflammation in patients who did not undergo regression after HspE7 immunotherapy. Local inflammation did not correlate with type-specific HPV infection or systemic T cell responses to HPV peptides; however, this study may have been underpowered to predict these observations in this subset of women with heterogeneous T cell responses. Further studies are currently underway.

About HspE7, Lead Product Candidate:

------------------------------------

HspE7 is a novel therapeutic vaccine candidate for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. HspE7 is derived from Nventa's proprietary CoVal(TM) fusion platform, which uses recombinant DNA technology to covalently fuse stress proteins to target antigens, thereby stimulating cellular immune system responses. Stress proteins, also known as heat shock proteins (Hsps), are naturally present in the human body and play important roles in the immune system, including transporting substances within cells and activating cells of the immune system. Nventa is pursuing clinical development of HspE7 in combination with an adjuvant.

About Nventa Corporation:

-------------------------

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Excha
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:11/26/2009)...ca, Nov. 26 The 2009 Frost & S...the Generic Pharmaceutical Market is presented to ...ttp://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO...llowing criteria were used to benchmark Cipla Medp...trategy and implementation, degree of innovation i...
(Date:11/25/2009)... American Scientific Reso...pleased to announce that they have opened a region...hanghai, China. ,, ASR has been able to secure ...for the development and production of current and ... adults to be distributed and sold globally. Curr...
(Date:11/25/2009)...PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or...r, manufacturer and supplier of premium diagnostic...edicated to serving the healthcare needs of women,...ociety of North America (RSNA) at McCormick Place ...o highlight our new SecurView(®) DX multimoda...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4U M Doctor Working to Get Neurologists in the Game When it Comes to Sports Injuries 59318 1U M Doctor Working to Get Neurologists in the Game When it Comes to Sports Injuries 59318 2U M Doctor Working to Get Neurologists in the Game When it Comes to Sports Injuries 59318 3Clinical Remissions in Three Otherwise Intractable Cancers Signal the Progress of Targeted Genetic Medicine 14438 1Clinical Remissions in Three Otherwise Intractable Cancers Signal the Progress of Targeted Genetic Medicine 14438 2Clinical Remissions in Three Otherwise Intractable Cancers Signal the Progress of Targeted Genetic Medicine 14438 3Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov 11 5404 1
...ith 48-week boceprevir-based ...o reported for 28-week boceprevir arm, KENILWORTH... SGP ) today reported top-line results from a pla...revir, its investigational,oral hepatitis C protea...ustained virologic response (SVR) in patients rece...
... Sanofi,Pasteur, the vaccines division of sanofi-...luzone(R), Influenza Virus Vaccine) in the United,...lion doses of influenza,vaccine began shipping thi...009 formulation by the U.S. Food and Drug Administ... to health-care providers and to the Centers for,D...
Other Medicine Technology:Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 5
(Date:11/27/2009)...ist manufacturers who use medical load cells at th...ollars by bringing in technology partner Flintec e...pro-active medical manufacturers are calling in Fl...eir projects, ensuring that progress will not be c...ally outdated technology. , ...
(Date:11/26/2009)...r of Americans living with diabetes will nearly do... million in 2034. Over the same period, spending o...llion to $336 billion, even with no increase in th...University of Chicago report in the December issue...diabetes covered by Medicare will rise from 8.2 mi...
(Date:11/26/2009)... letters from the North Pole, Textsanta.net lets p... Santa , North Pole, AK (...iciencies at the North Pole Santa Claus has added ...the globe informed of his Christmas progress at th...department have identified a large and growing per...
(Date:11/26/2009)...amp; Ennis, P.A. is offering free nationwide confi...birth control pills who have suffered a Deep Vein ...t Attack or other related cardiac issues or had th...at 1-800-856-6405 or go to the firm’s websit...ine case evaluation form. , ...
(Date:11/25/2009)... Nov. 25 /PRNewswire/ - Sentinelle Medical Inc., a...g (MRI) coils and software and Calgary Scientific ...nologies, have introduced a web version of Aegis(T..., This innovative interface is the first truly zer...ing in the market. Calgary Scientific,s PureWeb(TM...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...RNewswire-FirstCall/ -- InfoLogix, Inc. (Nas...terprise mobility solutions for the healthcare and...y has entered into an agreement with Gwinnett Med...stem in the emergency department. , , (Logo: ht...
...l 23 Valeant Pharmaceuticals International (NYSE:...rence call and a live Internet webcast along with ...:00 a.m. EDT (7:00 a.m. PDT) to discuss results fo...should dial (973) 200-3961, confirmation code 9423...
... 23 /PRNewswire-Asia-FirstCall/ -- Genesis,Pharmac...PH) (the "Company"),a U.S. pharmaceutical company ...blic of China, today announced that it has changed... that the Certificate of Amendment to the Company,...
...wswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASD...f its first quarter fiscal 2009 results conference...st Quarter Results Conference Call , , On Thursda...quarter 2009 financial results via news release at...
...ine With or Exceed Expectations , , DENVER, April...e largest air medical transportation company in th...009 earnings exceed expectations. Expected earnin...maintenance and fuel expense. , , Total community...
...al in establishing day to honor mom , , GROVE CIT...iversary for the Fraternal Order of Eagles ( htt...Durham. The step-mother and grandmother understand...day in May was designated Mother,s Day by Presiden...
Other Medicine News:Health News:InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution 2Health News:InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution 3Health News:Valeant Pharmaceuticals to Announce 2009 First Quarter Results on May 5, 2009 2Health News:Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name 2Health News:Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name 3Health News:Labopharm announces details for first quarter results conference call and annual meeting 2Health News:Air Methods' Preliminary 1st Qtr. Results Exceed Expectations 2Health News:Air Methods' Preliminary 1st Qtr. Results Exceed Expectations 3Health News:Fraternal Order of Eagles Grand Madam President Celebrates Mother's Day 2
...s two system in one. Uncomplicated design and ease...es. Quick-connect angled blades of anodized alumin... visualization. Aluminium blades allow for intra-o...tractor bodies, both longitudinal and transverse, ...
Scoville Cervical Disc Retractor
...uperior retractor blade stability and image friend...ne retraction objectives. The Image-line's color-c...lade size determination. The wide range of blade o...edures. Patents pending blade hub and frame graspe...
Cervical Retractor Handle - Small
Medicine Products: